MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, WVE has $241,378K in assets. $108,955K in debts. $196,218K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
250.87%
Cash Ratio
228.44%
Debt to Asset Ratio
45.14%
Assets Breakdown
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Accounts receivable
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Ordinary shares, no par value 16...
    • Additional paid-in capital
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
196,218 208,481
Accounts receivable
10,000 1,617
Prepaid expenses
6,653 6,700
Other current assets
2,617 6,758
Total current assets
215,488 223,556
Property and equipment, net of accumulated depreciation of 48,755 and 46,329 as of september 30, 2025 and december 31, 2024, respectively
8,196 9,037
Operating lease right-of-use assets
13,876 15,250
Restricted cash
3,796 3,784
Other assets
22 728
Total long-term assets
25,890 28,799
Total assets
241,378 252,355
Accounts payable
14,490 14,664
Accrued expenses and other current liabilities
16,487 13,026
Current portion of deferred revenue
46,525 51,582
Current portion of operating lease liability
8,394 8,136
Total current liabilities
85,896 87,408
Deferred revenue, net of current portion
11,681 4,232
Operating lease liability, net of current portion
11,378 13,575
Total long-term liabilities
23,059 17,807
Total liabilities
108,955 105,215
Series a preferred shares, no par value 3,901,348 shares issued and outstanding at september 30, 2025 and december 31, 2024
7,874 7,874
Ordinary shares, no par value 160,288,481 and 153,037,286 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
1,223,721 1,191,029
Additional paid-in capital
174,075 167,603
Accumulated other comprehensive loss
-190 -161
Accumulated deficit
-1,273,057 -1,219,205
Total shareholders' equity
124,549 139,266
Total liabilities, series a preferred shares, and shareholders' equity
241,378 252,355
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Other assets$22K Restricted cash$3,796K Operating leaseright-of-use assets$13,876K Property and equipment,net of accumulated...$8,196K Other current assets$2,617K Prepaid expenses$6,653K Accounts receivable$10,000K Cash and cashequivalents$196,218K Total long-termassets$25,890K Total current assets$215,488K Total assets$241,378K Total liabilities,series a preferred...$241,378K Total shareholders'equity$124,549K Series a preferredshares, no par value...$7,874K Total liabilities$108,955K Accumulated deficit-$1,273,057K Accumulated othercomprehensive loss-$190K Additional paid-in capital$174,075K Total long-termliabilities$23,059K Total currentliabilities$85,896K Ordinary shares, no parvalue 160,288,481 and...$1,223,721K Operating leaseliability, net of current...$11,378K Deferred revenue, net ofcurrent portion$11,681K Current portion ofoperating lease liability$8,394K Current portion ofdeferred revenue$46,525K Accrued expenses andother current...$16,487K Accounts payable$14,490K

Wave Life Sciences Ltd. (WVE)

Wave Life Sciences Ltd. (WVE)